Metformin Affects Olaparib Sensitivity through Induction of Apoptosis in Epithelial Ovarian Cancer Cell Lines
This study examined the effect of combination treatment with the poly (ADP-ribose) polymerase inhibitor olaparib and metformin on homologous recombination (HR)-proficient epithelial ovarian cancer (EOC). Ovarian cancer cell lines (OV-90 and SKOV-3) were treated with olaparib, metformin, or a combina...
Main Authors: | Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak, Aneta Rogalska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/19/10557 |
Similar Items
-
Olaparib-Resistant <i>BRCA2</i><sup>MUT</sup> Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival
by: Łukasz Biegała, et al.
Published: (2023-03-01) -
Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer
by: Arkadiusz Gajek, et al.
Published: (2021-05-01) -
Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer
by: Patrycja Gralewska, et al.
Published: (2020-04-01) -
Profile of olaparib in the treatment of advanced ovarian cancer
by: Chase DM, et al.
Published: (2016-04-01) -
The Influence of PARP, ATR, CHK1 Inhibitors on Premature Mitotic Entry and Genomic Instability in High-Grade Serous <i>BRCA<sup>MUT</sup></i> and <i>BRCA<sup>WT</sup></i> Ovarian Cancer Cells
by: Patrycja Gralewska, et al.
Published: (2022-06-01)